Literature DB >> 30945967

Vaccination among HIV-infected, HIV-exposed uninfected and HIV-uninfected children: a systematic review and meta-analysis of evidence related to vaccine efficacy and effectiveness.

Olatunji O Adetokunboh1,2, Duduzile Ndwandwe1, Ajibola Awotiwon3, Olalekan A Uthman1,2,4, Charles S Wiysonge1,2,5.   

Abstract

Evidence-based approaches were used in making recommendations for vaccination against vaccine-preventable diseases for HIV-infected and HIV-exposed individuals but with limited substantiation. We conducted a systematic review and meta-analysis with randomized-controlled trials (RCTs), cohort and case-control studies that have efficacy and effectiveness of vaccines in HIV-infected and HIV-exposed children as outcomes. Web of Science, Cochrane Library, PubMed and Scopus databases were searched for articles. Efficacy of 9-valent pneumococcal conjugate vaccine (PCV9) against total vaccine serotype invasive pneumococcal disease was 32% in HIV-infected children and 78% among HIV-uninfected children. Vaccine effectiveness of Bacillus Calmette-Guérin vaccine in preventing tuberculosis in HIV-infected children was zero compared to 59% protection in HIV-unexposed children. Likewise, HIV-uninfected children have better protection against invasive Haemophilus influenzae type b disease than the HIV-infected children. Effectiveness studies of rotavirus vaccines show that HIV-exposed uninfected children have similar protection against rotavirus gastroenteritis compared to the non-exposed children. Children who are severely immunosuppressed are poorly protected against invasive pneumococcal diseases. HIV-infected children tend to have lesser vaccine protection against vaccine-preventable diseases when compared to unexposed children. HIV-infected children who are immunocompetent are more likely to have better vaccine protection against vaccine-preventable diseases than those who are immunosuppressed. The overall quality of the observational studies was very low with very little confidence in the effect estimate. The overall quality of evidence for the RCT outcomes was mainly high. This study reveals a dearth of efficacy and effectiveness studies among HIV-infected and exposed children.

Entities:  

Keywords:  HIV; effectiveness; efficacy; sub-Saharan Africa; vaccine-preventable diseases

Mesh:

Substances:

Year:  2019        PMID: 30945967      PMCID: PMC6930074          DOI: 10.1080/21645515.2019.1599677

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  33 in total

1.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

2.  BCG vaccines: WHO position paper – February 2018.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2018-02-23

Review 3.  The broad socioeconomic benefits of vaccination.

Authors:  David E Bloom; Victoria Y Fan; J P Sevilla
Journal:  Sci Transl Med       Date:  2018-05-16       Impact factor: 17.956

4.  Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.

Authors:  Shabir A Madhi; Peter Adrian; Locadiah Kuwanda; Wasilla Jassat; Stephanie Jones; Tessa Little; Anu Soininen; Clare Cutland; Keith P Klugman
Journal:  Vaccine       Date:  2006-09-20       Impact factor: 3.641

5.  The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.

Authors:  Shabir A Madhi; Locadiah Kuwanda; Clare Cutland; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2005-04-07       Impact factor: 9.079

6.  Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.

Authors:  Kayla F Laserson; Daveline Nyakundi; Daniel R Feikin; Geoffrey Nyambane; Earnest Cook; Janet Oyieko; Joel Ojwando; Stephen B Rivers; Max Ciarlet; Kathleen M Neuzil; Robert F Breiman
Journal:  Vaccine       Date:  2012-04-27       Impact factor: 3.641

7.  Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.

Authors:  Shabir A Madhi; Karen Petersen; Manikant Khoosal; Robin E Huebner; Nontombi Mbelle; Rosalia Mothupi; Haroon Saloojee; Heather Crewe-Brown; Keith P Klugman
Journal:  Pediatr Infect Dis J       Date:  2002-04       Impact factor: 2.129

8.  Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants.

Authors:  A C Hesseling; M F Cotton; C Fordham von Reyn; S M Graham; R P Gie; G D Hussey
Journal:  Int J Tuberc Lung Dis       Date:  2008-12       Impact factor: 2.373

9.  Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study.

Authors:  Michelle J Groome; Nicola Page; Margaret M Cortese; Jocelyn Moyes; Heather J Zar; Constant N Kapongo; Christine Mulligan; Ralph Diedericks; Cheryl Cohen; Jessica A Fleming; Mapaseka Seheri; Jeffrey Mphahlele; Sibongile Walaza; Kathleen Kahn; Meera Chhagan; A Duncan Steele; Umesh D Parashar; Elizabeth R Zell; Shabir A Madhi
Journal:  Lancet Infect Dis       Date:  2014-10-07       Impact factor: 25.071

10.  Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis.

Authors:  Eleonora A M L Mutsaerts; Marta C Nunes; Martijn N van Rijswijk; Kerstin Klipstein-Grobusch; Diederick E Grobbee; Shabir A Madhi
Journal:  EClinicalMedicine       Date:  2018-07-02
View more
  7 in total

1.  Immune surveillance for six vaccinable pathogens using paired plasma and dried blood spots in HIV infected and uninfected children in Kinshasa.

Authors:  A Rodríguez-Galet; M Rubio-Garrido; A Valadés-Alcaraz; M Rodríguez-Domínguez; J C Galán; A Ndarabu; G Reina; A Holguín
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.996

Review 2.  Vaccination for the Prevention of Infection among Immunocompromised Patients: A Concise Review of Recent Systematic Reviews.

Authors:  Kay Choong See
Journal:  Vaccines (Basel)       Date:  2022-05-18

3.  Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B.

Authors:  Elvira Couto; Vicenç Diaz-Brito; Beatriz Mothe; Alberto C Guardo; Irene Fernandez; Ainoa Ugarte; Flor Etcheverry; Carmen E Gómez; Mariano Esteban; Judit Pich; Joan Albert Arnaiz; Juan Carlos López Bernaldo de Quirós; Christian Brander; Montserrat Plana; Felipe García; Lorna Leal
Journal:  Vaccines (Basel)       Date:  2019-11-07

4.  Humoral response to SARS-CoV-2 vaccines in people living with HIV.

Authors:  Sebastian Noe; Nino Ochana; Carmen Wiese; Farhad Schabaz; Ariane Von Krosigk; Silke Heldwein; Rudolf Rasshofer; Eva Wolf; Celia Jonsson-Oldenbuettel
Journal:  Infection       Date:  2021-10-25       Impact factor: 7.455

5.  Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial.

Authors:  Talía Sainz; Laura Diaz; David Rojo; María Isabel Clemente; Coral Barbas; María José Gosalbes; Nuria Jimenez-Hernandez; Luis Escosa; Sara Guillen; José Tomás Ramos; María Ángeles Muñoz-Fernández; María Luisa Navarro; María José Mellado; Sergio Serrano-Villar
Journal:  Nutrients       Date:  2022-02-26       Impact factor: 5.717

6.  Impact of industry sponsorship on the quality of systematic reviews of vaccines: a cross-sectional analysis of studies published from 2016 to 2019.

Authors:  Dawid Pieper; Irma Hellbrecht; Linlu Zhao; Clemens Baur; Georgia Pick; Sarah Schneider; Thomas Harder; Kelsey Young; Andrea C Tricco; Ella Westhaver; Matthew Tunis
Journal:  Syst Rev       Date:  2022-08-22

7.  Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial.

Authors:  Talía Sainz; Inmaculada Casas; Mónica González-Esguevillas; Luis Escosa-Garcia; María Ángeles Muñoz-Fernández; Luis Prieto; María José Gosalbes; Nuria Jiménez-Hernández; José Tomas Ramos; María Luisa Navarro; María José Mellado; Sergio Serrano-Villar; Cristina Calvo
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.